Archive | health care RSS feed for this section

Physician Compensation Methodology Must Change!

  In our current health care environment, most professional services are paid on a fee-for-service basis. The payment is usually from a third-party administrator or an insurance company. Many only supply a partial payment, expecting the remainder to be billed to the patient. Although much in our lives have similar processes (ie fee for service), […]

Read more
doctor shaking hands with female patient

Building Trust in the Profession: What Can We Learn from Choosing Wisely?

  The Choosing Wisely campaign sought to prompt physician–patient conversations about unnecessary care. At its 2012 launch, physicians and patients felt uncomfortable about “denying” even unnecessary or potentially harmful care. Opponents of the Affordable Care Act raised fears of rationing and death panels. Physicians and patients had long mistrusted the motives of third parties, including […]

Read more

In a Critical State: Ongoing Barriers to Treatment for Hepatitis C Virus (HCV)

5 Recent advances in hepatitis C virus (HCV) treatment could be described as revolutionary: for uncomplicated patients, treatment is nearly 100% effective, oral only, has a low pill burden, minimal side effects, and results in a cure.1 Comparisons we have heard from clinicians are that HCV is now easier to treat than either diabetes or hypertension. […]

Read more
William H. Frishman, M.D.

Medicine as a Meritocracy

                When we (the authors, WF and JA) were graduating from medical school in 1969, 50 years ago, our class pictures in Boston showed a predominance of white males, a small percentage of white females, and even fewer African Americans, Asian Americans, and Hispanic Americans. Today the class […]

Read more

Assessment and Treatment of Physician Speechlessness

What does a doctor say when words don’t come? Such was my dilemma several years ago on an inpatient psychiatric service when I responded to an emergency alarm activated by staff in a patient’s room. A young female patient—call her Lisa—had just knotted some latex gloves around her neck, and her face was still plethoric […]

Read more
microscope and test tubes

The Tradeoff of Cancer Drug Regulatory Policy: Faster Approvals for One Means Less Knowledge for Another

The popular narrative surrounding cancer drugs or other therapies for rare diseases is that patients are willing to assume more risk and uncertainty to gain rapid access to investigational agents. This is, in part, the impetus behind the frequent use of surrogate endpoints by the US Food and Drug Administration (FDA)1 and European Medicines Agency,2 as well […]

Read more